PODD NASDAQ
Insulet Corporation
1W: -2.4%
1M: -23.0%
3M: -40.1%
YTD: -45.4%
1Y: -52.4%
3Y: -53.2%
5Y: -31.4%
$155.50
+0.90 (+0.58%)
Weekly Expected Move ±10.3%
$117
$132
$147
$163
$178
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$1.8M
Congress—
ETF Holdings—
Key Statistics
Market Cap$10.7B
52W Range145.59-354.88
Volume1,367,717
Avg Volume1,212,893
Beta1.20
Dividend—
Analyst Ratings
Company Info
CEOAshley A. McEvoy
Employees5,400
SectorHealthcare
IndustryMedical - Devices
IPO Date2007-05-15
Websiteinsulet.com
100 Nagog Park
Acton, MA 01720
US
Acton, MA 01720
US
978 600 7000
About Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Latest News
Why Goldman Sachs Trimmed Insulet Corporation (PODD) Price Target Despite Strong Q1 Results
Here's Why Insulet (PODD) is a Strong Growth Stock
Why Insulet (PODD) is a Top Value Stock for the Long-Term
Notable healthcare headlines for the week: UnitedHealth, Pfizer, and CVS Health in focus
Most healthcare companies report higher Y/Y EPS in strong earnings week
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| McEvoy Ashley | F-InKind | 1,411 | $148.84 | 2026-05-13 |
| Panos Michael | A-Award | 7,255 | $207.04 | 2026-04-01 |
| Panos Michael | A-Award | 2,777 | — | 2026-04-01 |
| Huffines Robert Luth | A-Award | 111 | $209.84 | 2026-03-31 |
| Panos Michael | 0 | — | 2026-03-30 |